In-vivo MRI of noradrenergic and dopaminergic nuclei predicts future cognition and Alzheimers disease progression
Wenhui Zhao, Samuel J Guzman, Hyun Joo Yoo, Kacey Ruiz, Keran Chen, Ariel Moheban, Daniel A Nation, Martin J Dahl, Mara Mather
The paper uses in-vivo MRI to measure noradrenergic and dopaminergic nuclei integrity in ADNI participants, finding these measures predict future cognitive decline and Alzheimer's progression.
bioRxiv · Nov 2, 2026 · PreprintNeuroscience